GLP1R and neurodegenerative disease: These effects include the well-investigated anorexigenic effects, outlined below, as well as a range of neuroprotective abilities that have led to the use of GLP-1R agonists as therapies in human trials for a range of neurodegenerative diseases as discussed in detail further below.